HCAT vs WY · rev $141.2M vs P/E 43, rev $3.59B
Health Catalyst Inc (HCAT) versus Weyerhaeuser Company (WY) — a side-by-side from cached financials, not a winner call.
Health Catalyst Inc (HCAT) is a health information services company listed on NASDAQ.
Weyerhaeuser Company (WY) is a reit - specialty company listed on NYSE.
Latest reported HCAT revenue for 2026-06-30 was $141.2M. Net income was -$151.6M. Revenue was up 99.6% from 2026-03-31 to 2026-06-30. HCAT currently screens at market cap $130.8M.
Latest reported WY revenue for 2026-06-30 was $3.59B. Net income was $318.0M. WY currently screens at market cap $17.54B and trailing P/E 43.4.
HCAT currently screens at market cap $130.8M. WY currently screens at market cap $17.54B and trailing P/E 43.4.
Not investment advice. Open the HCAT and WY stock pages for the full models.
Not investment advice.